Beam Therapeutics Inc.
US ˙ NasdaqGS ˙ US07373V1052

SecurityBEAM / Beam Therapeutics Inc.
InstitutionDavy Global Fund Management Ltd
Latest Disclosed Ownership488,417 shares
Latest Disclosed Value $ 11,638,977
Davy Global Fund Management Ltd reports 8.46% decrease in ownership of BEAM / Beam Therapeutics Inc.

On May 11, 2026 - Davy Global Fund Management Ltd filed a 13F-HR form disclosing ownership of 488,417 shares of Beam Therapeutics Inc. (US:BEAM) valued at $11,638,977 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 533,563 shares of Beam Therapeutics Inc.. This represents a change in shares of -8.46% during the quarter. The current value of the position is $14,432,722 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BEAM THERAPEUTICS COM 07373V105 488,417 -45,146 -8.46 11,639 -21.31 0.8838
2026-02-12 2025-12-31 13F BEAM THERAPEUTICS COM 07373V105 533,563 150,032 39.12 14,790 58.90 1.0204
2025-11-05 2025-09-30 13F BEAM THERAPEUTICS COM 07373V105 383,531 188,243 96.39 9,308 180.28 0.6308
2025-08-01 2025-06-30 13F BEAM THERAPEUTICS COM 07373V105 195,288 130,036 199.28 3,322 160.68 0.2954
2025-05-09 2025-03-31 13F BEAM THERAPEUTICS COM 07373V105 65,252 33,054 102.66 1,274 59.65 0.1500
2025-02-12 2024-12-31 13F BEAM THERAPEUTICS COM 07373V105 32,198 19,080 145.45 799 148.60 0.0943
2024-10-16 2024-09-30 13F BEAM THERAPEUTICS COM 07373V105 13,118 3,815 41.01 321 47.93 0.0335
2024-07-29 2024-06-30 13F BEAM THERAPEUTICS COM 07373V105 9,303 9,303 218 0.0249
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.